Leukotriene Antagonists: all 255 studies that test it

Page 3 of 3. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Investigation to Identify Predictors of Response to a Treatment With MontelukastCompletedNCT00721240Phase 4
• A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)CompletedNCT00700661Phase 3
• Effect of Montelukast on the Airway RemodelingCompletedNCT00699062Phase 4
• Effects of Montelukast in Children With AsthmaCompletedNCT00675285Phase 3
• Add-on Salmeterol Versus Montelukast in Arg/Arg-16 AsthmaticsCompletedNCT00655616Not applicable
• Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea SyndromeWithdrawnNCT00599534Phase 2
• Zileuton and Exhaled Nitric Oxide in AsthmaticsCompletedNCT00575861Phase 4
• Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in ChildrenCompletedNCT00565955Phase 3
• Montelukast as a Controller of Atopic SyndromeCompletedNCT00559546Phase 4
• Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled StudyStatus unknownNCT00551382Phase 3
• First Step With Singulair® Therapy (0476-323)CompletedNCT00545324Phase 4
• Leukotriene Receptor Antagonists or Steroids in Pre-School AsthmaCompletedNCT00543686Phase 2
• A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)WithdrawnNCT00540839Phase 3
• Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma PatientsCompletedNCT00534625Phase 2
• Montelukast in Acute RSV BronchiolitisCompletedNCT00524693Not applicable
• Trial of Montelukast in Eosinophilic EsophagitisCompletedNCT00511316Phase 1
• Pharmacological Modulations of Allergen-Specific ImmunotherapyCompletedNCT00504946Phase 3
• Montelukast With Status Asthmaticus, Ages 6-18Status unknownNCT00494572Phase 2/3
• Montelukast in Very Low Birthweight InfantsCompletedNCT00492102Phase 1
• Montelukast With Status Asthmaticus, Ages 2-5Status unknownNCT00491790Phase 2/3
• Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic RhinitisStatus unknownNCT00488176Phase 4
• Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With AsthmaCompletedNCT00487773Phase 4
• Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)TerminatedNCT00471809Phase 4
• Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced BronchoconstrictionCompletedNCT00462592Phase 3
• The Effect of Montelukast in Patients With Chronic Cough and Bronchial HyperreactivityCompletedNCT00453765Phase 4
• Airway Responses to Montelukast and Desloratadine.CompletedNCT00424580Not applicable
• Study of ONO-1078 in Patients With Chronic SinusitisCompletedNCT00410735Phase 3
• Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)Status unknownNCT00406094Phase 4
• PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)CompletedNCT00394069Phase 2
• Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart DiseaseTerminatedNCT00351364Phase 4
• Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable TabletsCompletedNCT00328718Phase 3
• Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)CompletedNCT00319995Phase 3
• Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)CompletedNCT00319488Not applicable
• Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust MiteWithdrawnNCT00311051Phase 2/3
• Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered BreathingStatus unknownNCT00299910Phase 4
• Safety Study of Zileuton Injection in Patients With AsthmaCompletedNCT00299065Phase 1/2
• Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
• Exercise Induced Bronchospasm in ChildrenCompletedNCT00273689Phase 4
• Study With GW274150 In Patients With Mild AsthmaCompletedNCT00273013Phase 1
• Zileuton for the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT00262405Phase 2
• Use of Montelukast to Treat Children With Mild to Moderate Acute AsthmaCompletedNCT00213252Phase 2
• Montelukast in Modulating Exacerbations of Asthma in ChildrenCompletedNCT00196547Phase 4
• A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00162864Phase 3
• Montelukast in the Treatment of Duodenal EosinophiliaCompletedNCT00148603Not applicable
• Trial of Asthma Patient Education (TAPE)CompletedNCT00148408Phase 4
• A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)CompletedNCT00140881Phase 4
• An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)CompletedNCT00127647Phase 3
• Predicting the Response to Montelukast by Genetic Variation in AsthmaticsCompletedNCT00116324Phase 3
• Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne VulgarisStatus unknownNCT00098358Phase 2
• Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)CompletedNCT00092989Phase 3
• An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)CompletedNCT00092885Phase 3
• Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)CompletedNCT00092105Phase 3
• An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)CompletedNCT00076973Phase 3
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
• Zileuton in Preventing Lung Cancer in Patients With Bronchial DysplasiaCompletedNCT00056004Phase 2

← Leukotriene Antagonists overview